A-CAR028
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for A-CAR028, covering 2025-09-30 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]